Xiuzhuan Shang

Title: Innovations of Xiuzhuan Shang in Antitumor Drug Delivery Systems

Introduction

Xiuzhuan Shang is a notable inventor based in Tianjin, China. He has made significant contributions to the field of antitumor drug delivery systems. His innovative work focuses on enhancing the efficacy and targeting capabilities of antitumor drugs.

Latest Patents

Xiuzhuan Shang holds a patent for a "Ternary conjugate of antitumor drug, and synthesis and application." This patent discloses a targeted delivery system for a hydrophobic antitumor drug. The system involves conjugates of E-selectin polypeptide ligand-polyethylene glycol-antitumor drug connected by different link bridges containing disulfide bonds. The patent details the synthesis of these conjugates, evaluation of their antitumor activity, and the characteristics of nanoparticles self-assembled by the conjugates in an aqueous solution. The conjugates are designed to actively target tumor sites and demonstrate significant antitumor activity while being less toxic to normal cells.

Career Highlights

Xiuzhuan Shang is affiliated with Tianjin University of Science and Technology, where he conducts research and development in the field of drug delivery systems. His work has the potential to revolutionize the treatment of cancer by improving the targeting and effectiveness of antitumor therapies.

Collaborations

Xiuzhuan Shang collaborates with notable colleagues, including Peng Yu and Na Guo. Their combined expertise contributes to the advancement of innovative solutions in the field of antitumor drug delivery.

Conclusion

Xiuzhuan Shang's contributions to the development of targeted antitumor drug delivery systems highlight his role as a leading inventor in the field. His innovative approaches promise to enhance cancer treatment and improve patient outcomes.